Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 2:75:103448.
doi: 10.1016/j.amsu.2022.103448. eCollection 2022 Mar.

Female urogenital chlamydia: Epidemiology, chlamydia on pregnancy, current diagnosis, and treatment

Dian Tjahyadi  1   2 , Bejo Ropii  3 , Kevin Dominique Tjandraprawira  1   2 , Ida Parwati  4 , Tono Djuwantono  1 , Wiryawan Permadi  1 , Tinchiu Li  5
Affiliations
Review

Female urogenital chlamydia: Epidemiology, chlamydia on pregnancy, current diagnosis, and treatment

Dian Tjahyadi et al. Ann Med Surg (Lond). .

Abstract

Female urogenital chlamydia is a disease caused by Chlamydia trachomatis infection in the female urogenital tract. It is a common bacterial sexually transmitted disease. The bacteria is transmitted through sexual contact with an infected partner or from mother to newborn during vaginal delivery. The prevalence varies among studies and the number is possibly higher due to the lack of massive screening. Many patients were asymptomatic and still be able to transmit the disease. The undiagnosed and untreated disease could cause pelvic inflammatory disease, which leads to infertility, ectopic pregnancy, and chronic pelvic pain. The prevalence among pregnant women is similar to non-pregnant women, therefore chlamydia screening in pregnant women is highly recommended. The nucleic acid amplification test is the most reliable method for the diagnosis due to high sensitivity. The current treatment is given by prescribing antibiotics.

Keywords: Chlamydia trachomatis; Urogenital chlamydia.

PubMed Disclaimer

References

    1. Ojoo S. Clinical practice in sexually transmissible infections. McMillan A., Young H., Ogilvie M.M., Scott G.R., editors. Sex. Transm. Infect. Oct. 2003;79(5) doi: 10.1136/sti.79.5.429. Pp608; £93, 99, 2002. ISBN 0702025380. 429–429. - DOI
    1. Torrone E., Papp J., Weinstock H., Centers for Disease Control and Prevention (Cdc) Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb. Mortal. Wkly. Rep. Sep. 2014;63(38):834–838. - PMC - PubMed
    1. C. L. Satterwhite et al., “Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008,” Sex. Transm. Dis., vol. 40, no. 3, pp. 187–193, Mar. 2013, doi: 10.1097/OLQ.0b013e318286bb53. - PubMed
    1. Huai P., Li F., Chu T., Liu D., Liu J., Zhang F. Prevalence of genital Chlamydia trachomatis infection in the general population: a meta-analysis. BMC Infect. Dis. Aug. 2020;20(1):589. doi: 10.1186/s12879-020-05307-w. - DOI - PMC - PubMed
    1. K. M. Kreisel, E. J. Weston, S. B. St Cyr, and I. H. Spicknall, “Estimates of the prevalence and incidence of Chlamydia and gonorrhea among US men and women, 2018,” Sex. Transm. Dis., vol. 48, no. 4, pp. 222–231, Apr. 2021, doi: 10.1097/OLQ.0000000000001382. - PMC - PubMed